To include your compound in the COVID-19 Resource Center, submit it here.

Telaprevir regulatory update

FDA's Antiviral Drugs Advisory Committee voted 18-0 to recommend approval of telaprevir from Vertex to treat HCV infection. The panel members were impressed by the efficacy of telaprevir. In the Phase III program, telaprevir plus standard of care

Read the full 381 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers